Cordyceps sinensis ameliorates idiopathic pulmonary fibrosis in mice via inhibiting mitochondrion‐mediated oxidative stress
Idiopathic pulmonary fibrosis (IPF) represents a chronic interstitial lung disease with an unclear underlying mechanism and currently lacks a definitive treatment. Cordyceps sinensis (CS), renowned for its pharmacological properties in traditional Chinese medicine and extensive use in lung disease t...
Saved in:
| Published in | MedComm - Future medicine Vol. 3; no. 3 |
|---|---|
| Main Authors | , , , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Wiley
01.09.2024
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Idiopathic pulmonary fibrosis (IPF) represents a chronic interstitial lung disease with an unclear underlying mechanism and currently lacks a definitive treatment. Cordyceps sinensis (CS), renowned for its pharmacological properties in traditional Chinese medicine and extensive use in lung disease treatment, holds promise as a therapeutic agent for IPF. However, the specific role of CS in treating IPF remains unclear. In this study, we aimed to assess the efficacy of CS in treating IPF and unravel potential underlying mechanisms. Our results demonstrate that CS treatment effectively mitigated pulmonary inflammation and collagen deposition in bleomycin‐induced IPF mice. Proteomics analysis revealed that the regulation of mitochondrial oxidative phosphorylation may serve as a potential protective mechanism of CS against IPF in mice. Further investigation unveiled that CS could suppress the excessive production of mitochondrial reactive oxygen species in lung tissues induced by bleomycin through moderating the expression and activity of mitochondrial complexes, thus safeguarding the integrity and function of mitochondria. Overall, our findings not only underscore the effectiveness of CS in preventing bleomycin‐induced IPF but also highlight mitochondrial‐mediated oxidative stress as a promising therapeutic target for treating IPF.
Cordyceps sinensis demonstrates efficacy in reducing mitochondrial reactive oxygen species (mitROS) production and mitigating oxidative stress and inflammation by targeting mitochondrial complexes I and II. These mechanisms contribute to its therapeutic effect in pulmonary fibrosis. |
|---|---|
| AbstractList | Abstract Idiopathic pulmonary fibrosis (IPF) represents a chronic interstitial lung disease with an unclear underlying mechanism and currently lacks a definitive treatment. Cordyceps sinensis (CS), renowned for its pharmacological properties in traditional Chinese medicine and extensive use in lung disease treatment, holds promise as a therapeutic agent for IPF. However, the specific role of CS in treating IPF remains unclear. In this study, we aimed to assess the efficacy of CS in treating IPF and unravel potential underlying mechanisms. Our results demonstrate that CS treatment effectively mitigated pulmonary inflammation and collagen deposition in bleomycin‐induced IPF mice. Proteomics analysis revealed that the regulation of mitochondrial oxidative phosphorylation may serve as a potential protective mechanism of CS against IPF in mice. Further investigation unveiled that CS could suppress the excessive production of mitochondrial reactive oxygen species in lung tissues induced by bleomycin through moderating the expression and activity of mitochondrial complexes, thus safeguarding the integrity and function of mitochondria. Overall, our findings not only underscore the effectiveness of CS in preventing bleomycin‐induced IPF but also highlight mitochondrial‐mediated oxidative stress as a promising therapeutic target for treating IPF. Idiopathic pulmonary fibrosis (IPF) represents a chronic interstitial lung disease with an unclear underlying mechanism and currently lacks a definitive treatment. Cordyceps sinensis (CS), renowned for its pharmacological properties in traditional Chinese medicine and extensive use in lung disease treatment, holds promise as a therapeutic agent for IPF. However, the specific role of CS in treating IPF remains unclear. In this study, we aimed to assess the efficacy of CS in treating IPF and unravel potential underlying mechanisms. Our results demonstrate that CS treatment effectively mitigated pulmonary inflammation and collagen deposition in bleomycin‐induced IPF mice. Proteomics analysis revealed that the regulation of mitochondrial oxidative phosphorylation may serve as a potential protective mechanism of CS against IPF in mice. Further investigation unveiled that CS could suppress the excessive production of mitochondrial reactive oxygen species in lung tissues induced by bleomycin through moderating the expression and activity of mitochondrial complexes, thus safeguarding the integrity and function of mitochondria. Overall, our findings not only underscore the effectiveness of CS in preventing bleomycin‐induced IPF but also highlight mitochondrial‐mediated oxidative stress as a promising therapeutic target for treating IPF. Idiopathic pulmonary fibrosis (IPF) represents a chronic interstitial lung disease with an unclear underlying mechanism and currently lacks a definitive treatment. Cordyceps sinensis (CS), renowned for its pharmacological properties in traditional Chinese medicine and extensive use in lung disease treatment, holds promise as a therapeutic agent for IPF. However, the specific role of CS in treating IPF remains unclear. In this study, we aimed to assess the efficacy of CS in treating IPF and unravel potential underlying mechanisms. Our results demonstrate that CS treatment effectively mitigated pulmonary inflammation and collagen deposition in bleomycin‐induced IPF mice. Proteomics analysis revealed that the regulation of mitochondrial oxidative phosphorylation may serve as a potential protective mechanism of CS against IPF in mice. Further investigation unveiled that CS could suppress the excessive production of mitochondrial reactive oxygen species in lung tissues induced by bleomycin through moderating the expression and activity of mitochondrial complexes, thus safeguarding the integrity and function of mitochondria. Overall, our findings not only underscore the effectiveness of CS in preventing bleomycin‐induced IPF but also highlight mitochondrial‐mediated oxidative stress as a promising therapeutic target for treating IPF. Cordyceps sinensis demonstrates efficacy in reducing mitochondrial reactive oxygen species (mitROS) production and mitigating oxidative stress and inflammation by targeting mitochondrial complexes I and II. These mechanisms contribute to its therapeutic effect in pulmonary fibrosis. |
| Author | Tang, Huan Guo, Qiuyan Zhang, Junzhe Zhou, Lirun Zhou, Yanyan Zhang, Ying Cheng, Guangqing Wu, Jiangpeng Wong, Yin K. Wang, Jigang |
| Author_xml | – sequence: 1 givenname: Ying surname: Zhang fullname: Zhang, Ying organization: China Academy of Chinese Medical Sciences – sequence: 2 givenname: Lirun surname: Zhou fullname: Zhou, Lirun organization: China Academy of Chinese Medical Sciences – sequence: 3 givenname: Guangqing surname: Cheng fullname: Cheng, Guangqing organization: China Academy of Chinese Medical Sciences – sequence: 4 givenname: Yanyan surname: Zhou fullname: Zhou, Yanyan organization: China Academy of Chinese Medical Sciences – sequence: 5 givenname: Qiuyan surname: Guo fullname: Guo, Qiuyan organization: China Academy of Chinese Medical Sciences – sequence: 6 givenname: Jiangpeng surname: Wu fullname: Wu, Jiangpeng organization: China Academy of Chinese Medical Sciences – sequence: 7 givenname: Yin K. surname: Wong fullname: Wong, Yin K. organization: National University of Singapore – sequence: 8 givenname: Junzhe surname: Zhang fullname: Zhang, Junzhe organization: China Academy of Chinese Medical Sciences – sequence: 9 givenname: Huan orcidid: 0000-0003-4772-9483 surname: Tang fullname: Tang, Huan email: htang@icmm.ac.cn organization: China Academy of Chinese Medical Sciences – sequence: 10 givenname: Jigang orcidid: 0000-0002-0575-0105 surname: Wang fullname: Wang, Jigang email: jgwang@icmm.ac.cn organization: Henan University |
| BookMark | eNp1kc9qVTEQxoNUsNbiK2TnQk5Ncv5mKZdWCxU3ug5zkknvlHOSSxKrd1HwEXxGn8Rcr4Iorubj48c3fDNP2UmIARl7LsWFFEK9WtGrCy0fsVM1DroZun44-UM_Yec534lKTmOrRnXKHjYxub3FXeaZAoZMmcOKC8UEBTMnR3EHZUuW7z4tawyQ9tzTnOKBpMBXssjvCare0kyFwm31SrTbGFyiGL5__baio5rmePxCDgrdI88lYc7P2GMPS8bzX_OMfby6_LB529y8f3O9eX3TWDX2svFK-16IUegZJSK6SSM423nvOhTCS-3l0Ao9gmr7YRIOJt9OMM4We9QttGfs-pjrItyZXaK11jARyPw0Yro1kArZBY2bwYpBeDVPqlNTB7OVo1B6aKe5VX1fs5pjlq03yAm9sVRqqRhKAlqMFObwCnN4hdGy8i_-4n_v_5d8eSQ_04L7_2Hm3eWVqvQP20Gd3Q |
| CitedBy_id | crossref_primary_10_1016_j_foodchem_2025_143863 crossref_primary_10_3390_biology13090683 crossref_primary_10_3390_jof11010051 crossref_primary_10_2147_JIR_S508098 |
| Cites_doi | 10.1183/13993003.03551-2020 10.15537/smj.2016.5.14953 10.1089/ars.2019.7742 10.1183/13993003.00398-2016 10.3390/molecules28145393 10.1016/j.jep.2023.116284 10.3389/fphys.2015.00036 10.1016/j.apsb.2022.08.022 10.1016/S0140-6736(11)60052-4 10.1016/S0140-6736(17)30866-8 10.1042/EBC20190052 10.1074/jbc.M803236200 10.1038/ncomms14532 10.1155/2015/645814 10.1007/s00408-023-00608-8 10.1152/ajplung.00593.2020 10.1016/j.freeradbiomed.2009.09.026 10.1111/j.1440-1843.2003.00523.x 10.5858/arpa.2011-0511-OA 10.1016/S0140-6736(20)30925-9 10.3349/ymj.2023.0131 10.1007/s10753-019-01059-1 10.1164/rccm.201903-0542UP 10.3390/ijms18020367 10.3389/fphar.2022.915592 10.1016/j.intimp.2022.109465 10.1016/j.arbres.2013.08.004 10.1016/j.bbrc.2023.05.092 10.3390/antiox11020307 10.1016/j.biocel.2022.106361 10.1183/09059180.00008713 10.2174/138161213804143626 10.1089/rej.2006.9.169 10.1016/S0891-5849(03)00316-2 10.1016/j.fct.2004.12.008 10.1164/rccm.202004-1274OC 10.1016/j.phymed.2023.154707 10.1136/thoraxjnl-2011-200515 10.1016/j.ijbiomac.2020.04.163 10.1152/ajplung.00410.2011 10.3389/fonc.2022.811183 10.1016/j.cbi.2023.110603 10.3389/fphar.2021.794997 10.7150/thno.81993 10.1186/s12931-018-0754-7 10.1016/j.jep.2023.116772 10.1023/A:1027374931887 10.1016/j.bcp.2010.05.025 10.1016/j.intimp.2022.109427 10.4149/av_2018_104 10.3390/molecules25122735 10.1016/j.redox.2014.12.011 10.1513/AnnalsATS.201605-341AW 10.1172/jci.insight.163762 10.1080/14728222.2018.1541318 10.3389/fphar.2022.939488 10.3390/nano13152265 |
| ContentType | Journal Article |
| Copyright | 2024 The Author(s). published by John Wiley & Sons Australia, Ltd on behalf of Sichuan International Medical Exchange & Promotion Association (SCIMEA). |
| Copyright_xml | – notice: 2024 The Author(s). published by John Wiley & Sons Australia, Ltd on behalf of Sichuan International Medical Exchange & Promotion Association (SCIMEA). |
| DBID | 24P AAYXX CITATION DOA |
| DOI | 10.1002/mef2.91 |
| DatabaseName | Wiley Online Library Open Access CrossRef Open Access Journals (DOAJ) |
| DatabaseTitle | CrossRef |
| DatabaseTitleList | CrossRef |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2769-6456 |
| EndPage | n/a |
| ExternalDocumentID | oai_doaj_org_article_dbac060f2b824284abc17029638b3255 10_1002_mef2_91 MEF291 |
| Genre | article |
| GrantInformation_xml | – fundername: The Innovation Team and Talents Cultivation Program of the National Administration of Traditional Chinese Medicine funderid: ZYYCXTD‐C‐202002 – fundername: National Natural Science Foundation of China funderid: 32201177; 82074098 – fundername: the Science and Technology Foundation of Shenzhen – fundername: National Key Research and Development Program of China funderid: 2020YFA0908000 – fundername: The Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences funderid: CI2023E002‐Y‐30; CI2023E005TS01; CI2023D003; CI2021B014; CI2021A05101 – fundername: The Fundamental Research Funds for the Central public welfare research institutes funderid: ZZ14‐YQ‐061; ZZ16‐ND‐1024 |
| GroupedDBID | 0R~ 24P 7X7 8FI 8FJ AAMMB ABUWG ACCMX ADPDF AEFGJ AFKRA AGXDD AIDQK AIDYY ALMA_UNASSIGNED_HOLDINGS BENPR CCPQU EBS FYUFA GROUPED_DOAJ HMCUK M~E PHGZM PHGZT PIMPY TEORI UKHRP WIN AAYXX CITATION PUEGO |
| ID | FETCH-LOGICAL-c2751-f29f500709be1eeed89eadc4ffd4e00f19f163097a235680da8f38a7bce5e93a3 |
| IEDL.DBID | 24P |
| ISSN | 2769-6456 |
| IngestDate | Wed Aug 27 01:31:01 EDT 2025 Thu Apr 24 23:03:24 EDT 2025 Tue Jul 01 02:56:18 EDT 2025 Wed Aug 20 07:26:10 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Language | English |
| License | Attribution |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c2751-f29f500709be1eeed89eadc4ffd4e00f19f163097a235680da8f38a7bce5e93a3 |
| Notes | Ying Zhang, Lirun Zhou, and Guangqing Cheng contributed equally to this work. |
| ORCID | 0000-0003-4772-9483 0000-0002-0575-0105 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmef2.91 |
| PageCount | 19 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_dbac060f2b824284abc17029638b3255 crossref_citationtrail_10_1002_mef2_91 crossref_primary_10_1002_mef2_91 wiley_primary_10_1002_mef2_91_MEF291 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | September 2024 2024-09-00 2024-09-01 |
| PublicationDateYYYYMMDD | 2024-09-01 |
| PublicationDate_xml | – month: 09 year: 2024 text: September 2024 |
| PublicationDecade | 2020 |
| PublicationTitle | MedComm - Future medicine |
| PublicationYear | 2024 |
| Publisher | Wiley |
| Publisher_xml | – name: Wiley |
| References | 2017; 8 2020; 64 2023; 382 2021; 203 2023; 8 2004; 9 2022; 26 2012; 18 2023; 669 2016; 37 2023; 309 2014; 23 2019; 200 2013; 19 2023; 28 1997; 17 2024; 65 2020; 43 2012; 136 2012; 67 2014; 50 2014; 7 2016; 48 2022; 322 2011; 378 2023; 13 2015; 6 2015; 4 2019; 31 2023; 201 2006; 9 2003; 35 2005; 43 2018; 62 2010; 80 2018; 22 2012; 302 2016; 13 2008; 283 2022; 113 2018; 19 2021; 57 2010; 48 2013; 33 2020; 396 2023; 112 2023; 155 2015; 2015 2022; 12 2022; 13 2020; 25 2017; 18 2020; 157 2023; 317 2022; 11 2017; 389 Shi K (e_1_2_11_30_1) 2014; 7 Kage H (e_1_2_11_33_1) 2012; 18 e_1_2_11_32_1 e_1_2_11_55_1 e_1_2_11_57_1 e_1_2_11_36_1 e_1_2_11_51_1 e_1_2_11_34_1 e_1_2_11_53_1 e_1_2_11_11_1 e_1_2_11_29_1 e_1_2_11_6_1 e_1_2_11_27_1 e_1_2_11_4_1 e_1_2_11_48_1 e_1_2_11_2_1 e_1_2_11_60_1 e_1_2_11_20_1 e_1_2_11_45_1 e_1_2_11_47_1 Huang RF (e_1_2_11_62_1) 2013; 33 e_1_2_11_24_1 e_1_2_11_41_1 e_1_2_11_8_1 e_1_2_11_22_1 e_1_2_11_17_1 e_1_2_11_15_1 e_1_2_11_59_1 e_1_2_11_38_1 e_1_2_11_19_1 Roksandic Milenkovic M (e_1_2_11_43_1) 2022; 26 e_1_2_11_50_1 e_1_2_11_10_1 e_1_2_11_31_1 e_1_2_11_56_1 e_1_2_11_58_1 e_1_2_11_14_1 e_1_2_11_35_1 e_1_2_11_52_1 e_1_2_11_12_1 e_1_2_11_54_1 e_1_2_11_7_1 e_1_2_11_28_1 e_1_2_11_5_1 e_1_2_11_26_1 e_1_2_11_3_1 e_1_2_11_49_1 e_1_2_11_61_1 e_1_2_11_21_1 e_1_2_11_44_1 e_1_2_11_46_1 e_1_2_11_25_1 e_1_2_11_40_1 e_1_2_11_9_1 e_1_2_11_23_1 e_1_2_11_42_1 e_1_2_11_18_1 e_1_2_11_16_1 e_1_2_11_37_1 e_1_2_11_39_1 Zhao P (e_1_2_11_13_1) 2015; 2015 |
| References_xml | – volume: 12 year: 2022 article-title: Targeting oxidative stress as a therapeutic approach for idiopathic pulmonary fibrosis publication-title: Front Pharmacol – volume: 283 start-page: 21649 issue: 31 year: 2008 end-page: 21654 article-title: The mechanism of mitochondrial superoxide production by the cytochrome bc1 complex publication-title: J Biol Chem – volume: 309 year: 2023 article-title: Cordyceps proteins alleviate lupus nephritis through modulation of the STAT3/mTOR/NF‐кB signaling pathway publication-title: J Ethnopharmacol – volume: 43 start-page: 1 issue: 1 year: 2020 end-page: 7 article-title: Oxidant/antioxidant disequilibrium in idiopathic pulmonary fibrosis pathogenesis publication-title: Inflammation – volume: 12 start-page: 4011 issue: 11 year: 2022 end-page: 4039 article-title: New opportunities and challenges of natural products research: when target identification meets single‐cell multiomics publication-title: Acta Pharm Sin B – volume: 13 year: 2022 article-title: Bailing capsule ( ) ameliorates renal triglyceride accumulation through the PPARα pathway in diabetic rats publication-title: Front Pharmacol – volume: 203 start-page: 707 issue: 6 year: 2021 end-page: 717 article-title: Senescence of alveolar type 2 cells drives progressive pulmonary fibrosis publication-title: Am J Respir Crit Care Med – volume: 26 start-page: 927 issue: 3 year: 2022 end-page: 934 article-title: Oxidative stress and inflammation parameters‐novel biomarkers for idiopathic pulmonary fibrosis publication-title: Eur Rev Med Pharmacol Sci – volume: 13 start-page: S417 issue: suppl 5 year: 2016 end-page: S421 article-title: Lung fibroblasts, aging, and idiopathic pulmonary fibrosis publication-title: Ann Am Thorac Soc – volume: 19 start-page: 441 issue: 3 year: 2013 end-page: 451 article-title: HSP60 as a drug target publication-title: Curr Pharm Des – volume: 18 start-page: 517 issue: 5 year: 2012 end-page: 523 article-title: EMT and interstitial lung disease: a mysterious relationship publication-title: Curr Opin Pulm Med – volume: 25 start-page: 2735 issue: 12 year: 2020 article-title: Cordycepin for health and wellbeing: a potent bioactive metabolite of an entomopathogenic medicinal fungus cordyceps with its nutraceutical and therapeutic potential publication-title: Molecules – volume: 31 start-page: 1092 issue: 14 year: 2019 end-page: 1115 article-title: Redox imbalance in idiopathic pulmonary fibrosis: a role for oxidant cross‐talk between NADPH oxidase enzymes and mitochondria publication-title: Antioxid Redox Signaling – volume: 13 start-page: 2265 issue: 15 year: 2023 article-title: The effect of nanobubble water containing Cordyceps extract and withaferin a on free fatty acid‐induced lipid accumulation in HepG2 cells publication-title: Nanomaterials – volume: 113 issue: Pt B year: 2022 article-title: Long course of low‐dose dexamethasone following or after bleomycin administration ameliorates pulmonary fibrosis publication-title: Int Immunopharmacol – volume: 19 start-page: 51 issue: 1 year: 2018 article-title: Evaluation of oxidative stress biomarkers in idiopathic pulmonary fibrosis and therapeutic applications: a systematic review publication-title: Respir Res – volume: 382 year: 2023 article-title: Geranylgeranylacetone, an inducer of heat shock protein 70, attenuates pulmonary fibrosis via inhibiting NF‐κB/NOX4/ROS signalling pathway in vitro and in vivo publication-title: Chemico‐Biological Interactions – volume: 322 start-page: L449 issue: 3 year: 2022 end-page: L461 article-title: The profibrotic and senescence phenotype of old lung fibroblasts is reversed or ameliorated by genetic and pharmacological manipulation of Slc7a11 expression publication-title: Am J Physiol Lung Cell Mol Physiol – volume: 7 start-page: 2645 issue: 9 year: 2014 end-page: 2650 article-title: Dexamethasone attenuates bleomycin‐induced lung fibrosis in mice through TGF‐β, Smad3 and JAK‐STAT pathway publication-title: Int J Clin Exp Med – volume: 18 start-page: 367 issue: 2 year: 2017 article-title: Role of autophagy and apoptosis in non‐small‐cell lung cancer publication-title: Int J Mol Sci – volume: 35 start-page: 226 issue: 3 year: 2003 end-page: 235 article-title: ROS in the local and systemic pathogenesis of COPD publication-title: Free Radic Biol Med – volume: 669 start-page: 120 year: 2023 end-page: 127 article-title: Rev‐erbα agonists suppresses TGFβ1‐induced fibroblast‐to‐myofibroblast transition and pro‐fibrotic phenotype in human lung fibroblasts publication-title: Biochem Biophys Res Commun – volume: 12 year: 2022 article-title: The effect of ophiopogonin C in ameliorating radiation‐induced pulmonary fibrosis in C57BL/6 mice: an update study publication-title: Front Oncol – volume: 11 start-page: 307 issue: 2 year: 2022 article-title: p62‐Nrf2 regulatory loop mediates the anti‐pulmonary fibrosis effect of bergenin publication-title: Antioxidants – volume: 17 start-page: 3 issue: 1 year: 1997 end-page: 8 article-title: Superoxide production by the mitochondrial respiratory chain publication-title: Biosci Rep – volume: 8 issue: 3 year: 2023 article-title: Inhibition of antiapoptotic BCL‐2 proteins with ABT‐263 induces fibroblast apoptosis, reversing persistent pulmonary fibrosis publication-title: JCI Insight – volume: 67 start-page: 742 issue: 8 year: 2012 end-page: 746 article-title: Idiopathic pulmonary fibrosis publication-title: Thorax – volume: 389 start-page: 1941 issue: 10082 year: 2017 end-page: 1952 article-title: Idiopathic pulmonary fibrosis publication-title: Lancet – volume: 13 start-page: 2787 issue: 9 year: 2023 end-page: 2799 article-title: Pharmacological inhibition of MDM4 alleviates pulmonary fibrosis publication-title: Theranostics – volume: 48 start-page: 1 issue: 1 year: 2010 end-page: 15 article-title: Oxidative stress and glutathione in TGF‐beta‐mediated fibrogenesis publication-title: Free Radic Biol Med – volume: 43 start-page: 543 issue: 4 year: 2005 end-page: 552 article-title: Free radical scavenging and apoptotic effects of fractionated by supercritical carbon dioxide publication-title: Food Chem Toxicol – volume: 9 start-page: 169 issue: 2 year: 2006 end-page: 181 article-title: Extracellular redox state: refining the definition of oxidative stress in aging publication-title: Rejuvenation Res – volume: 396 start-page: 1204 issue: 10258 year: 2020 end-page: 1222 article-title: Global burden of 369 diseases and injuries in 204 countries and territories, 1990‐2019: a systematic analysis for the Global Burden of Disease Study 2019 publication-title: Lancet – volume: 50 start-page: 260 issue: 6 year: 2014 end-page: 261 article-title: Triple terapia en fibrosis pulmonar idiopática publication-title: Arch Bronconeumol – volume: 302 start-page: L721 issue: 8 year: 2012 end-page: L729 article-title: Emerging evidence for endoplasmic reticulum stress in the pathogenesis of idiopathic pulmonary fibrosis publication-title: Am J Physiol Lung Cell Mol Physiol – volume: 155 year: 2023 article-title: Roles of lipid metabolism and its regulatory mechanism in idiopathic pulmonary fibrosis: a review publication-title: Int J Biochem Cell Biol – volume: 57 issue: 1 year: 2021 article-title: Idiopathic pulmonary fibrosis: prime time for a precision‐based approach to treatment with N‐acetylcysteine publication-title: Eur Respir J – volume: 6 start-page: 36 year: 2015 article-title: Mitochondrial uncoupling proteins and energy metabolism publication-title: Front Physiol – volume: 23 start-page: 3 issue: 131 year: 2014 end-page: 4 article-title: Evolvement of best practice in diagnosis and management of idiopathic pulmonary fibrosis publication-title: Eur Respir Rev – volume: 65 start-page: 55 issue: 2 year: 2024 end-page: 69 article-title: Beneficial effects of low‐grade mitochondrial stress on metabolic diseases and aging publication-title: Yonsei Med J – volume: 112 year: 2023 article-title: Qimai Feiluoping decoction inhibits mitochondrial complex I‐mediated oxidative stress to ameliorate bleomycin‐induced pulmonary fibrosis publication-title: Phytomedicine – volume: 33 start-page: 1116 issue: 8 year: 2013 end-page: 1121 article-title: Effect of fermented cordyceps powder and prednisone on the Notch2/Hes‐1 signaling activation in the kidney tubules of rats with acute aristolochic acid nephropathy publication-title: Zhongguo Zhong Xi Yi Jie He Za Zhi – volume: 64 start-page: 111 issue: 1 year: 2020 end-page: 133 article-title: 3‐Nitrotyrosine and related derivatives in proteins: precursors, radical intermediates and impact in function publication-title: Essays Biochem – volume: 9 start-page: 25 issue: 1 year: 2004 end-page: 32 article-title: The influence of dexamethasone on the proliferation and apoptosis of pulmonary inflammatory cells in bleomycin‐induced pulmonary fibrosis in rats publication-title: Respirology – volume: 13 year: 2022 article-title: Clinical efficacy, safety, and cost of nine Chinese patent medicines combined with ACEI/ARB in the treatment of early diabetic kidney disease: a network meta‐analysis publication-title: Front Pharmacol – volume: 28 start-page: 5393 issue: 14 year: 2023 article-title: Medicinal mushrooms: their bioactive components, nutritional value and application in functional food production—a review publication-title: Molecules – volume: 113 issue: Pt B year: 2022 article-title: Entrectinib ameliorates bleomycin‐induced pulmonary fibrosis in mice by inhibiting TGF‐β1 signaling pathway publication-title: Int Immunopharmacol – volume: 136 start-page: 591 issue: 6 year: 2012 end-page: 600 article-title: Idiopathic pulmonary fibrosis may be a disease of recurrent, tractional injury to the periphery of the aging lung: a unifying hypothesis regarding etiology and pathogenesis publication-title: Arch Pathol Lab Med – volume: 378 start-page: 1949 issue: 9807 year: 2011 end-page: 1961 article-title: Idiopathic pulmonary fibrosis publication-title: Lancet – volume: 157 start-page: 394 year: 2020 end-page: 400 article-title: Antioxidant and anti‐aging activities of polysaccharides from Cordyceps cicadae publication-title: Int J Biiol Macromol – volume: 2015 start-page: 1 year: 2015 end-page: 10 article-title: Total glucosides of Danggui Buxue Tang attenuate BLM‐induced pulmonary fibrosis via regulating oxidative stress by inhibiting NOX4 publication-title: Oxid Med Cell Longevity – volume: 8 year: 2017 article-title: Cellular senescence mediates fibrotic pulmonary disease publication-title: Nat Commun – volume: 48 start-page: 538 issue: 2 year: 2016 end-page: 552 article-title: Age‐driven developmental drift in the pathogenesis of idiopathic pulmonary fibrosis publication-title: Eur Respir J – volume: 317 year: 2023 article-title: The protective effect of an extract of salvia miltiorrhiza Bunge (Danshen) on cerebral ischemic injury in animal models: a systematic review and meta‐analysis publication-title: J Ethnopharmacol – volume: 201 start-page: 235 issue: 2 year: 2023 end-page: 242 article-title: Deficiency of HtrA3 attenuates bleomycin‐induced pulmonary fibrosis via TGF‐β1/Smad signaling pathway publication-title: Lung – volume: 22 start-page: 1049 issue: 12 year: 2018 end-page: 1061 article-title: Oxidative/nitrosative stress, autophagy and apoptosis as therapeutic targets of melatonin in idiopathic pulmonary fibrosis publication-title: Expert Opin Ther Targets – volume: 4 start-page: 193 year: 2015 end-page: 199 article-title: Role of lipid peroxidation derived 4‐hydroxynonenal (4‐HNE) in cancer: focusing on mitochondria publication-title: Redox Biol – volume: 62 start-page: 33 issue: 1 year: 2018 end-page: 40 article-title: Functional role of Hsp60 as a positive regulator of human viral infection progression publication-title: Acta Virol – volume: 200 start-page: 292 issue: 3 year: 2019 end-page: 300 article-title: Update in pulmonary fibrosis 2018 publication-title: Am J Respir Crit Care Med – volume: 80 start-page: 920 issue: 6 year: 2010 end-page: 931 article-title: Heat shock protein 70 protects against bleomycin‐induced pulmonary fibrosis in mice publication-title: Biochem Pharmacol – volume: 37 start-page: 498 issue: 5 year: 2016 end-page: 505 article-title: Inhibitory effect of Bailing capsule on hypoxia‐induced proliferation of rat pulmonary arterial smooth muscle cells publication-title: Saudi Med J – ident: e_1_2_11_51_1 doi: 10.1183/13993003.03551-2020 – ident: e_1_2_11_23_1 doi: 10.15537/smj.2016.5.14953 – ident: e_1_2_11_53_1 doi: 10.1089/ars.2019.7742 – ident: e_1_2_11_7_1 doi: 10.1183/13993003.00398-2016 – ident: e_1_2_11_56_1 doi: 10.3390/molecules28145393 – ident: e_1_2_11_25_1 doi: 10.1016/j.jep.2023.116284 – ident: e_1_2_11_35_1 doi: 10.3389/fphys.2015.00036 – ident: e_1_2_11_49_1 doi: 10.1016/j.apsb.2022.08.022 – ident: e_1_2_11_3_1 doi: 10.1016/S0140-6736(11)60052-4 – ident: e_1_2_11_5_1 doi: 10.1016/S0140-6736(17)30866-8 – ident: e_1_2_11_48_1 doi: 10.1042/EBC20190052 – ident: e_1_2_11_19_1 doi: 10.1074/jbc.M803236200 – ident: e_1_2_11_57_1 doi: 10.1038/ncomms14532 – volume: 2015 start-page: 1 year: 2015 ident: e_1_2_11_13_1 article-title: Total glucosides of Danggui Buxue Tang attenuate BLM‐induced pulmonary fibrosis via regulating oxidative stress by inhibiting NOX4 publication-title: Oxid Med Cell Longevity doi: 10.1155/2015/645814 – ident: e_1_2_11_31_1 doi: 10.1007/s00408-023-00608-8 – ident: e_1_2_11_38_1 doi: 10.1152/ajplung.00593.2020 – ident: e_1_2_11_21_1 doi: 10.1016/j.freeradbiomed.2009.09.026 – volume: 33 start-page: 1116 issue: 8 year: 2013 ident: e_1_2_11_62_1 article-title: Effect of fermented cordyceps powder and prednisone on the Notch2/Hes‐1 signaling activation in the kidney tubules of rats with acute aristolochic acid nephropathy publication-title: Zhongguo Zhong Xi Yi Jie He Za Zhi – ident: e_1_2_11_27_1 doi: 10.1111/j.1440-1843.2003.00523.x – volume: 18 start-page: 517 issue: 5 year: 2012 ident: e_1_2_11_33_1 article-title: EMT and interstitial lung disease: a mysterious relationship publication-title: Curr Opin Pulm Med – ident: e_1_2_11_9_1 doi: 10.5858/arpa.2011-0511-OA – ident: e_1_2_11_2_1 doi: 10.1016/S0140-6736(20)30925-9 – ident: e_1_2_11_39_1 doi: 10.3349/ymj.2023.0131 – ident: e_1_2_11_45_1 doi: 10.1007/s10753-019-01059-1 – ident: e_1_2_11_10_1 doi: 10.1164/rccm.201903-0542UP – ident: e_1_2_11_60_1 doi: 10.3390/ijms18020367 – ident: e_1_2_11_22_1 doi: 10.3389/fphar.2022.915592 – ident: e_1_2_11_28_1 doi: 10.1016/j.intimp.2022.109465 – ident: e_1_2_11_11_1 doi: 10.1016/j.arbres.2013.08.004 – volume: 7 start-page: 2645 issue: 9 year: 2014 ident: e_1_2_11_30_1 article-title: Dexamethasone attenuates bleomycin‐induced lung fibrosis in mice through TGF‐β, Smad3 and JAK‐STAT pathway publication-title: Int J Clin Exp Med – ident: e_1_2_11_34_1 doi: 10.1016/j.bbrc.2023.05.092 – ident: e_1_2_11_37_1 doi: 10.3390/antiox11020307 – ident: e_1_2_11_14_1 doi: 10.1016/j.biocel.2022.106361 – ident: e_1_2_11_12_1 doi: 10.1183/09059180.00008713 – ident: e_1_2_11_40_1 doi: 10.2174/138161213804143626 – ident: e_1_2_11_36_1 doi: 10.1089/rej.2006.9.169 – ident: e_1_2_11_17_1 doi: 10.1016/S0891-5849(03)00316-2 – volume: 26 start-page: 927 issue: 3 year: 2022 ident: e_1_2_11_43_1 article-title: Oxidative stress and inflammation parameters‐novel biomarkers for idiopathic pulmonary fibrosis publication-title: Eur Rev Med Pharmacol Sci – ident: e_1_2_11_55_1 doi: 10.1016/j.fct.2004.12.008 – ident: e_1_2_11_58_1 doi: 10.1164/rccm.202004-1274OC – ident: e_1_2_11_20_1 doi: 10.1016/j.phymed.2023.154707 – ident: e_1_2_11_8_1 doi: 10.1136/thoraxjnl-2011-200515 – ident: e_1_2_11_24_1 doi: 10.1016/j.ijbiomac.2020.04.163 – ident: e_1_2_11_61_1 doi: 10.1152/ajplung.00410.2011 – ident: e_1_2_11_29_1 doi: 10.3389/fonc.2022.811183 – ident: e_1_2_11_16_1 doi: 10.1016/j.cbi.2023.110603 – ident: e_1_2_11_52_1 doi: 10.3389/fphar.2021.794997 – ident: e_1_2_11_6_1 doi: 10.7150/thno.81993 – ident: e_1_2_11_44_1 doi: 10.1186/s12931-018-0754-7 – ident: e_1_2_11_46_1 doi: 10.1016/j.jep.2023.116772 – ident: e_1_2_11_18_1 doi: 10.1023/A:1027374931887 – ident: e_1_2_11_15_1 doi: 10.1016/j.bcp.2010.05.025 – ident: e_1_2_11_32_1 doi: 10.1016/j.intimp.2022.109427 – ident: e_1_2_11_41_1 doi: 10.4149/av_2018_104 – ident: e_1_2_11_42_1 doi: 10.3390/molecules25122735 – ident: e_1_2_11_47_1 doi: 10.1016/j.redox.2014.12.011 – ident: e_1_2_11_4_1 doi: 10.1513/AnnalsATS.201605-341AW – ident: e_1_2_11_59_1 doi: 10.1172/jci.insight.163762 – ident: e_1_2_11_50_1 doi: 10.1080/14728222.2018.1541318 – ident: e_1_2_11_26_1 doi: 10.3389/fphar.2022.939488 – ident: e_1_2_11_54_1 doi: 10.3390/nano13152265 |
| SSID | ssj0002873272 |
| Score | 2.2739522 |
| Snippet | Idiopathic pulmonary fibrosis (IPF) represents a chronic interstitial lung disease with an unclear underlying mechanism and currently lacks a definitive... Abstract Idiopathic pulmonary fibrosis (IPF) represents a chronic interstitial lung disease with an unclear underlying mechanism and currently lacks a... |
| SourceID | doaj crossref wiley |
| SourceType | Open Website Enrichment Source Index Database Publisher |
| SubjectTerms | bleomycin‐induced idiopathic pulmonary fibrosis Cordyceps sinensis mitochondria oxidative phosphorylation reactive oxygen species |
| SummonAdditionalLinks | – databaseName: Open Access Journals (DOAJ) dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3LSsQwFA3iQtyITxxfZCHuqk06bZOlygyDMK4cmF3JEyNjO8xDdCH4CX6jX-JNWocRETfuShqSkhxyz23uPRehUyDJllIhIsuIAQdF60hKaSIqMuWvhTKW-tzh_m3WG7RvhulwqdSXjwmr5YHrhbvQUqg4iy2VDKwJawupSB5TjxuZAB_2py_YvCVn6iH8MsoTmtM6S9arjF48GkvPOflmfoJK_3dWGsxKdxNtNHwQX9bfsYVWTLmN1vrNjfcOer0G7_BFmfEU-wj1cuqmWDyakc-sB5aInXZVqCqs8Hg-AkyJyQu24ANXvqcrsS83j5-cgOd7J52Pcoa2WQXHXqknsCsfb-8hfQSoJ66enQ5K4LjOIdlFg27n7roXNSUTIkXzlESWcpt6CR8uDTFg_xgHqKi2tbpt4tgSboGAxTwXNEkzFmvBbMJELpVJDU9EsodWy6o0-whLzQwRVBoNLlOe5SLl4PtwZSwMS4ltobOvlSxUoyfuy1qMiloJmRZ-yQtOWggvOo5rCY2fXa78Vixee83r0ABIKBokFH8hoYVOw0b-NknR73QpJwf_MdchWqfAbupgsyO0OpvMzTGwk5k8CUD8BImH57k priority: 102 providerName: Directory of Open Access Journals |
| Title | Cordyceps sinensis ameliorates idiopathic pulmonary fibrosis in mice via inhibiting mitochondrion‐mediated oxidative stress |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fmef2.91 https://doaj.org/article/dbac060f2b824284abc17029638b3255 |
| Volume | 3 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La9wwEBYlhdBLSZOWbpoGHUJvbqzxSzomYZcQ2NJDA7kZPVtDYi_rTUgPKf0J-Y35JZmR3W1DKfRijD2ykUaPb6SZbxg7QJAcALROghQeDRTnEmOMT0CXlo6FSllQ7PD8U3l6np9dFBd_pPoa-CHWG240MuJ8TQNcm_7wN2nolQ_wkeLWn1NgLXnzQf55vb2ChkAGMXUTVKVKSsQJQ8gslT4cyz5ZiyJl_1OIGteY2RZ7OYJDfjRo8xV75ttttjkfj7932N0JmorfrV_0nNzV277pub7CepAefc8b13QxxbDli-tL7GBYOx6wlh1JNi2n3PP8ptF4_60xDbk847NVh3Ng65aoooef9zGWBHEo724bF2nB-RBQ8pqdz6ZfTk6TMX9CYqEqRBJAhYL4fJTxwuNiKBX2G5uH4HKfpkGogGgsVZWGrChl6rQMmdSVsb7wKtPZG7bRdq1_y7hx0gsNxjts7KqsdKHQEFLWB_wsiDBhH361ZG1HcnHKcXFZD7TIUFOT10pMGF8LLgY-jb9FjkkV69dEgB0fdMuv9Tieame0Tcs0gJEIMmSujRVVCjSdmAzNpAk7iIr810_q-XQGSuz-n9g79gIQzAy-ZXtsY7W89u8RjKzMfux2-9GUx-v8x_QRQLni0A |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3NbtQwELZKkaAXxK9Yfn0o3ELjSeLYBw6ldLWl3YpDK_UW_EsjtclqswV6QOIR-hw8Fk_C2EkXVQiJS2-RM3Kc8dj-xvZ8Q8g6gmQPoFTiBXPooFibaK1dAoqbcCzERRFih6f7fHKYfzgqjlbIz8tYmJ4fYrnhFkZGnK_DAA8b0ht_WENPnYc3kg0XKnfd-Vd017q3O--xb18BjLcPtibJkFEgMVAWLPEgfREYbqR2zOHyICRq0uTe29ylqWfSIz5JZakgK7hIrRI-E6rUxhVOZirDem-QmzmHMmRLgPzjcj8HPY8MYq4oKLlMOAKTPkY3tHZjaOuVxS_mCLiKieOiNr5L7gxolG725nOPrLjmPrk1Hc7bH5DvW_iz58bNOhruxzdd3VF1iooLhuM6Wtu6jTmNDZ2dnaBFozqpR7W2QbJuaEh2T7_UCp-Pa12HO9ZYtmhx0m3sHG3i14-LGLyCwJe232obechpH8HykBxei3ofkdWmbdxjQrUVjinQzqLDVvJSFRI9L2mcx2qB-RF5fanJygxs5iGpxknV8zBDFVReSTYidCk46wk8_hZ5F7pi-TowbseCdv65GgZwZbUyKU89aIGoRuRKG1amEOYvnaFfNiLrsSP_9ZFquj0GyZ78n9hLcntyMN2r9nb2d5-SNUAk1V9se0ZWF_Mz9xyR0EK_iCZIyafrtvnfLzkfFQ |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIlVcEE-xlIcPhVtoPHn60AO0XbWUrXqgUm_BT4jUJqvNttBDJX4Cf4O_1V_SsZMuqhASl94ix3Kc8dj-xp75BmCNQLJDlDJyJbdkoBgTKaVshDLX_looLzMfOzzZz3cO049H2dES_L6Ohen5IRYHbn5mhPXaT_Cpcet_SENPrMN3gg_-lHv2_DtZa93G7hYN7RvE8fbnzZ1oSCgQaSwyHjkULvMEN0JZbml3KAUJUqfOmdTGsePCETyJRSExyfIyNrJ0SSkLpW1mRSITavcO3PVXi957DNODxXEOGR4JhlRRWOQiygmX9CG6vrfrQ19v7H0hRcBNSBz2tPEDuD-AUfa-156HsGSbR7AyGa7bH8PFJv3subbTjnn3-KarOyZPSG5eb2zHalO3IaWxZtPTY1JokiZzJNXW16wb5nPds7Na0vO3WtXexZrK5i2tuY2ZkUpc_vwVYlcI97L2R20CDTnrA1iewOGtiPcpLDdtY58BU6a0XKKyhuy1Ii9kJsjwEto6aha5G8Hba0lWeiAz9zk1jquehhkrL_JK8BGwRcVpz9_xd5UPfigWrz3hdihoZ1-rYf5WRkkd57FDVRKoKVOpNC9i9MuXSsgsG8FaGMh_faSabI9R8Of_V-01rBxsjatPu_t7q3APCUf1bm0vYHk-O7UvCQfN1auggQy-3LbKXwFVyR5H |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cordyceps+sinensis+ameliorates+idiopathic+pulmonary+fibrosis+in+mice+via+inhibiting+mitochondrion%E2%80%90mediated+oxidative+stress&rft.jtitle=MedComm+-+Future+medicine&rft.au=Zhang%2C+Ying&rft.au=Zhou%2C+Lirun&rft.au=Cheng%2C+Guangqing&rft.au=Zhou%2C+Yanyan&rft.date=2024-09-01&rft.issn=2769-6456&rft.eissn=2769-6456&rft.volume=3&rft.issue=3&rft_id=info:doi/10.1002%2Fmef2.91&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_mef2_91 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2769-6456&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2769-6456&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2769-6456&client=summon |